◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › D › DHR

Danaher Corporation (DHR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Life Sciences Tools & Services · DATA UPDATED 2026-08-16

Danaher Corporation (DHR) operates in the Life Sciences Tools & Services industry and is headquartered in Washington, United States with about 58,000 employees. Its market capitalization is roughly $149 billion. In the fiscal year ended 2025-12-31, DHR reported $24.6B in revenue and $3.6B in net income.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.

Interactive charts & full statements → Open the DHR valuation workbench →

DHR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$25.1B	$24.6B	$23.9B	$23.9B	$26.6B	$29.5B	$22.3B	$17.9B	$17.0B	$18.3B	$16.9B	$14.4B	$19.9B	$19.1B	$18.3B	$16.1B	$13.2B	$11.2B	$12.7B	$11.0B	$9.6B
Gross Profit	$14.7B	$15.0B	$14.2B	$14.0B	$16.2B	$18.0B	$12.5B	$10.0B	$9.5B	$10.2B	$9.4B	$7.9B	$10.5B	$10.0B	$9.4B	$8.2B	$6.6B	$5.4B	$6.0B	$5.0B	$4.2B
Gross Margin %	58.5%	60.9%	59.5%	58.7%	60.8%	61.0%	56.0%	55.7%	55.8%	55.8%	55.6%	54.8%	52.7%	52.2%	51.7%	51.2%	50.2%	48.3%	47.0%	45.7%	44.2%
Operating Income (EBIT)	$5.1B	$5.1B	$5.2B	$5.2B	$7.5B	$8.1B	$4.3B	$3.4B	$3.1B	$3.1B	$3.0B	$2.4B	$3.6B	$3.4B	$3.2B	$2.7B	$2.2B	$1.7B	$2.0B	$1.7B	$1.5B
Operating Margin %	20.4%	20.9%	21.7%	21.8%	28.3%	27.3%	19.4%	18.8%	18.0%	17.2%	17.7%	16.8%	18.1%	17.6%	17.5%	17.0%	16.9%	15.5%	15.4%	15.7%	15.7%
Net Income	$4.0B	$3.6B	$3.9B	$4.7B	$7.2B	$6.4B	$3.6B	$2.6B	$2.7B	$2.5B	$2.6B	$2.6B	$2.6B	$2.7B	$2.3B	$2.0B	$1.8B	$1.2B	$1.3B	$1.2B	$1.1B
Net Margin %	16.0%	14.7%	16.3%	19.9%	27.1%	21.8%	16.4%	14.3%	15.6%	13.6%	15.1%	18.0%	13.1%	14.1%	12.6%	12.2%	13.6%	10.3%	10.4%	11.1%	11.7%
EBITDA	$7.2B	$6.9B	$7.3B	$5.2B	$9.5B	$10.0B	$6.5B	$4.6B	$4.3B	$4.3B	$3.9B	$3.1B	$4.5B	$4.6B	$4.0B	$3.2B	$2.9B	$1.9B	$2.2B	$2.0B	$1.7B
Earnings Per Share (EPS)	$5.63	$5.08	$5.29	$6.38	$9.78	$8.73	$5.07	$3.52	$3.73	$3.53	$3.65	$3.67	$3.63	$3.79	$3.22	$2.81	$2.62	$1.72	$1.96	$1.85	$1.72
Shares Outstanding (M)	708M	711M	737M	743M	737M	737M	719M	726M	710M	706M	700M	708M	716M	711M	713M	701M	683M	671M	672M	659M	651M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DHR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$6.3B	$6.0B	$6.8B	$6.1B	$5.9B	$5.7B	$6.5B	$5.8B
Gross Profit	$3.6B	$3.6B	$4.0B	$3.5B	$4.0B	$3.5B	$3.9B	$3.4B
Gross Margin %	57.6%	60.3%	58.0%	58.2%	66.6%	61.2%	59.5%	58.7%
Operating Income (EBIT)	$1.1B	$1.3B	$1.5B	$1.2B	$1.2B	$1.3B	$1.7B	$958M
Operating Margin %	18.0%	22.6%	22.0%	19.1%	20.1%	22.2%	26.7%	16.5%
Net Income	$870M	$1.0B	$1.2B	$908M	$555M	$954M	$1.1B	$818M
Net Margin %	13.9%	17.3%	17.5%	15.0%	9.3%	16.6%	16.6%	14.1%
EBITDA	$1.8B	$1.5B	$2.1B	$1.8B	$1.3B	$1.8B	$2.0B	$1.7B
Earnings Per Share (EPS)	$1.23	$1.45	$1.68	$1.27	$0.77	$1.32	$1.47	$1.12
Shares Outstanding (M)	708M	711M	711M	714M	719M	721M	737M	729M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DHR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$6.6B	$6.4B	$6.7B	$7.2B	$8.5B	$8.4B	$6.2B	$4.0B	$4.0B	$3.5B	$3.5B	$3.8B	$3.8B	$3.6B	$3.4B	$2.6B	$2.1B	$1.8B	$1.9B	$1.6B	$1.5B
Capital Expenditures (CapEx)	$1.2B	$1.2B	$1.4B	$1.4B	$1.2B	$1.3B	$791M	$636M	$584M	$571M	$590M	$513M	$465M	$538M	$458M	$334M	$217M	$189M	$194M	$162M	$138M
Free Cash Flow (FCF)	$5.5B	$5.3B	$5.3B	$5.8B	$7.4B	$7.1B	$5.4B	$3.3B	$3.4B	$2.9B	$2.9B	$3.3B	$3.3B	$3.0B	$3.0B	$2.3B	$1.9B	$1.6B	$1.7B	$1.5B	$1.4B
FCF Margin %	21.8%	21.4%	22.2%	24.2%	27.7%	24.0%	24.3%	18.5%	20.2%	15.9%	17.4%	22.8%	16.5%	15.9%	16.2%	14.2%	14.1%	14.4%	13.1%	13.5%	14.7%
Dividends Paid	$964M	$878M	$768M	$821M	$818M	$742M	$615M	$751M	$433M	$378M	$400M	$354M	$228M	$52M	$86M	$61M	$52M	$42M	$38M	$34M	$25M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DHR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$1.5B	$1.3B	$2.1B	$1.7B	$1.3B	$1.3B	$2.0B	$1.5B
Capital Expenditures (CapEx)	$269M	$237M	$371M	$292M	$248M	$245M	$516M	$298M
Free Cash Flow (FCF)	$1.3B	$1.1B	$1.7B	$1.4B	$1.1B	$1.1B	$1.5B	$1.2B
FCF Margin %	20.2%	18.2%	25.5%	22.6%	18.4%	18.4%	23.0%	21.0%
Dividends Paid	$283M	$226M	$226M	$229M	$229M	$194M	$195M	$196M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DHR Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$92.4B	$83.5B	$77.5B	$84.5B	$84.3B	$83.2B	$76.2B	$62.1B	$47.8B	$46.6B	$45.3B	$48.2B	$37.0B	$34.7B	$32.9B	$29.9B	$22.2B	$19.6B	$17.5B	$17.5B	$12.9B
Cash & Cash Equivalents	$4.3B	$4.6B	$2.1B	$5.9B	$6.0B	$2.6B	$6.0B	$19.9B	$788M	$630M	$964M	$791M	$3.0B	$3.1B	$1.7B	$537M	$1.6B	$1.7B	$393M	$239M	$318M
Total Liabilities	$39.8B	$30.9B	$28.0B	$31.0B	$34.3B	$38.0B	$36.4B	$31.8B	$19.6B	$20.3B	$22.2B	$24.5B	$13.5B	$12.2B	$13.9B	$13.0B	$8.4B	$8.0B	$7.7B	$8.4B	$6.2B
Total Debt (Short + Long-Term)	$26.6B	$18.4B	$16.2B	$18.6B	$19.8B	$22.4B	$21.4B	$21.9B	$9.7B	$10.5B	$12.3B	$12.9B	$3.5B	$3.5B	$5.3B	$5.3B	$2.8B	$2.9B	$2.6B	$3.7B	$2.4B
Total Shareholders' Equity	$52.6B	$52.5B	$49.5B	$53.5B	$50.1B	$45.2B	$39.8B	$30.3B	$28.2B	$26.4B	$23.0B	$23.7B	$23.4B	$22.4B	$19.0B	$16.9B	$13.7B	$11.6B	$9.8B	$9.1B	$6.6B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DHR viewer.

DHR Metric Deep Dives

Other Companies in Life Sciences Tools & Services

TMO · Thermo Fisher Scientific — $241 billion
A · Agilent Technologies — $44 billion
IQV · IQVIA — $44 billion
WAT · Waters Corporation — $41 billion
MTD · Mettler Toledo — $28 billion
CRL · Charles River Laboratories — $13 billion
TECH · Bio-Techne — $11 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← DHOOTTRANS All “D” companies DHRUV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.